How Prepared Are Psychiatry Residents for Treating Nicotine Dependence?

Transcription

1 Original Article How Prepared Are Psychiatry Residents for Treating Nicotine Dependence? Judith J. Prochaska, Ph.D., MPH, Sebastien C. Fromont, M.D. Sharon M. Hall, Ph.D. Objective: Nicotine dependence is the most prevalent substance abuse disorder among adult psychiatric patients and a leading cause of death and disability. The authors examined the extent to which psychiatry residents are prepared to treat nicotine dependence in clinical practice. Methods: Residents from five psychiatry residency programs in northern California completed an anonymous survey of their knowledge, attitudes, and behaviors regarding treating nicotine dependence among their patients. Results: Respondents (N 105, 60% female) represented all 4 years of residency training. Residents smoking status was 11% current, 17% former, and 72% never. Knowledge scores averaged 54% correct. Confidence ratings averaged 3 (SD 0.6) on a 5- point scale. Seventy six percent rated their overall ability to help patients quit using tobacco as fair or poor. The percent reporting often or always engaging in the National Cancer Institute s 5-A intervention for smoking cessation was: 58% ask; 29% advise; 17% assess; 18% assist; and 13% arrange follow up. Most residents reported none or inadequate tobacco cessation training during medical school (74%) or residency (79%), and nearly all (94%) reported moderate to high interest in learning more about helping patients quit smoking. Conclusion: Psychiatry residents appear unprepared to treat nicotine dependence, but report considerable interest in this area. The findings demonstrate the need for and interest in tobacco cessation curricula in psychiatry residency training. Academic Psychiatry 2005; 29: Received August 25, 2004; revised November 4, 2004; accepted November 11, Drs. Prochaska, Fromont, and Hall are all with the University of California San Francisco School of Medicine, Department of Psychiatry, San Francisco, California. Address correspondence to Dr. Prochaska, University of California San Francisco School of Medicine, Department of Psychiatry, 401 Parnassus Ave.- TRC 0984, San Francisco, CA ; JProchaska@lppi. ucsf.edu ( ). Copyright 2005 Academic Psychiatry. C igarette smoking accounts for 440,000 deaths in the U.S. each year and is the most preventable cause of morbidity and mortality (1). Quitting smoking at any age provides important health benefits and greater life expectancy (2). In terms of lives saved, quality of life, and costefficacy, treating smoking is considered one of the most important activities a clinician can do (3). While the prevalence of cigarette smoking among U.S. adults has declined since the first Surgeon General s report on smoking and health in 1964, rates remain elevated among psychiatric populations. The smoking prevalence among individuals with a current psychiatric illness is nearly double that of individuals without mental illness (41% versus 23%) and even higher among the seriously mentally ill and those with substance use disorders (4, 5). In California, the smoking rate for adults is among the lowest in the nation (17%), yet recent studies in northern California estimate the smoking prevalence at 28% among psychiatric outpatients and 45% among psychiatric inpatients (6 8). Psychiatric patients also tend to be heavy smokers, in the number of cigarettes smoked per day and in how deeply they inhale (9). It is estimated that 44% of the cigarettes sold in the U.S. are to the mentally ill (4). Cigarette smokers with psychiatric and substance use disorders are at high risk for smoking-related deaths (10, 11). Rates of cardiovascular and respiratory diseases and cancer are higher than those of age-matched controls (12, 13), with smoking believed to be a major contributing cause. Complicating treatment, the hydrocarbons of tar in cigarettes cause increased metabolism of some antipsychotic (e.g., clozapine, haloperidol, olanzapine) and antidepressant (e.g., nortriptyline) medications, which may lead to inadequate dosing, subtherapeutic blood levels, increased cost, and possibly even some neuroleptic side effects (e.g., tardive dyskinesia) (14). Financially, the smoking burden may be particularly difficult for individuals with severe mental illness, who are likely to be on a low income Academic Psychiatry, 29:3, July-August 2005

2 PROCHASKA ET AL. (15). Socially, in areas where smoking is prohibited, heavy smokers may find it difficult to participate, leading to further isolation. The U.S. Public Health Service recommends all patients be screened for tobacco use, advised to quit, and offered intervention (16). Evidence indicates the more intensive the cessation counseling, the greater its effectiveness. The guidelines also recommend use of pharmacotherapy with all smokers trying to quit, expect in special circumstances, with nicotine replacement therapy (NRT) and bupropion SR being first-line and nortriptyline and clonidine being second-line medications. An organizational framework for tobacco cessation intervention is the National Cancer Institute s 5-A intervention for physicians to ask about tobacco use, advise smokers to quit, assess readiness to quit, assist in quit attempts, and arrange follow up (17, 18). Given the complicated relationship between mental illness and smoking, integration of cessation efforts within psychiatric care is encouraged (19 21). The American Psychiatric Association s (APA) clinical guidelines for treating nicotine dependence recommend psychiatrists assess the smoking status of all their patients...discuss interest in quitting...[and provide] explicit advice to motivate the patient to stop smoking (19). A recent metaanalysis of randomized trials examining physician advice for smoking cessation indicated a significant treatment effect with an increase in the odds of patients quitting (22). Of 39 trials identified, however, not one was conducted in a psychiatric setting. A study analyzing data from the National Ambulatory Medical Care Survey may be the only published report on psychiatrists counseling for smoking cessation (23). Data were collected from independent practice settings. Of most concern, 23% of psychiatric visits had to be dropped from the analysis because patient smoking status was unknown. For patients identified as smokers (N 1610), psychiatrists reported offering cessation counseling at only 12% of visits. Diagnosis of Nicotine Dependence was not made at any visit, and NRT was never prescribed. A primary barrier to delivering smoking cessation counseling may be lack of training. A number of tobacco cessation curriculums have been developed and a recent systematic review of the literature suggested training health professionals to provide tobacco cessation interventions had a measurable effect on professional performance including offering counseling, setting quit dates and follow up visits, distributing self-help materials, and recommending NRT (24). Of the 10 trials identified, however, none was conducted with mental health professionals. Another factor may be low prioritization of tobacco use as an issue of relevance for psychiatric practice. The mental health, addictions, and tobacco control communities have largely ignored tobacco dependence among smokers with psychiatric disorders (25). Other potential barriers to counseling include beliefs that patients would not be interested in or able to quit, that patients need to smoke to manage their psychiatric symptoms, and that cessation attempts may exacerbate patients symptoms and/or threaten recovery from other substances of abuse (26). The extent to which psychiatry residency programs prepare their residents for identifying and treating nicotine dependence is unknown. The purpose of this study was to assess the need for and interest in tobacco cessation curricula in psychiatry residency training. We surveyed psychiatry residents on their knowledge, attitudes, and behaviors regarding interventions for treating tobacco dependence in clinical practice. Method Participants Our study was conducted with residents from five psychiatry residency programs in northern California. Residency lists provided by program training directors defined the recruitment pool. The survey was mailed and/or ed to the 155 identified residents. A cover letter explained the purpose of the survey and requested voluntary participation. Survey completion was considered consent to participate. This study was approved by the appropriate Institutional Review Boards. Measures A three-page self-report survey assessed participants : 1) knowledge of smoking rates, health effects, and treatments (8 items); 2) attitudes regarding clinical interventions for treating nicotine dependence (10 items); 3) engagement in smoking cessation counseling practices with their patients (i.e., the 5-A s) (6 items); 4) perceived confidence in their ability to counsel patients to quit smoking (6 items) with a rating of overall ability (1 item); 5) adequacy of prior training on smoking cessation (5 items); 6) interest in further training to help patients quit smoking (1 item); and 7) respondent characteristics (e.g., gender, level of training, advanced degrees, smoking status). Knowledge scores were calculated as the percent correct. Mean total scores were calculated for attitudes, behaviors, and confidence. Many of the items were used previously Academic Psychiatry, 29:3, July-August

3 RESIDENTS TREATING NICOTINE DEPENDENCE to evaluate the Rx for Change curriculum with more than 3,000 students of medicine, pharmacy, and nursing. The scales demonstrated good internal consistency previously (27) and with the current sample (Cronbach alpha s ranged from 0.79 to 0.84). The full measure is available upon request from the authors. Procedures Participants were instructed to complete the survey individually, which was anticipated to take less than 15 minutes. Respondents were asked to provide their name and address on a detachable coupon, for $5.00 reimbursement, and to return it by mail separately from the completed survey, thereby maintaining anonymity. Self-addressed, stamped return envelopes were provided. Nonresponders were sent a second survey. Analyses Descriptive analyses (means, frequencies) were used to summarize residents survey responses. Correlations tested associations among the constructs. Results Respondents Surveys were completed by 105 residents (68% response rate). The sample was 60% female; 19% held graduate degrees (M.P.H., Ph.D.) in addition to their medical training. Respondents were in their first (23%), second (22%), third (29%), or fourth (26%) year of residency training. Identified areas of specialized interest were psychotherapy (68%), biological psychiatry (61%), child psychiatry (23%), other (15%), and the addictions (13%). Respondents smoking status was 11% current, 17% former, and 72% never. There were no differences in smoking status by gender, year of training, advanced degree status, or area of specialty (all p s 0.05). The sample was representative of the residency recruitment pool with respect to gender (v , df 1, p 0.535), year of training (v , df 3, p 0.929), and residency site v , df 4, p 0.349). Knowledge, Attitudes, and Behaviors Respondents averaged 54% correct (SD 17; range: 12.5% to 100%) on the knowledge items. Endorsement of negative attitudes toward smoking cessation counseling in psychiatric practice averaged 2.1 (SD 0.6) on a 5-point scale ranging from 1 strongly disagree to 5 strongly agree. Responses by item are summarized in Table 1. Figure 1 shows respondents engagement in the 5-A s intervention for smoking cessation. The percent reporting often or always engaging in the 5-A s was: 58% ask, 29% advise, 17% assess, 18% assist, and 13% arrange follow up. Knowledge scores and engagement in the 5-A s were significantly correlated (r 0.21, p 0.034); neither was associated with the attitudes scale (p s 0.10). Males (r 0.27, p 0.005) and current tobacco users (r 0.29, p 0.002) endorsed more negative attitudes toward counseling patients to quit smoking. Knowledge scores and reported behaviors did not differ significantly by respondent characteristics (p s 0.10). Confidence and Overall Ability Confidence ratings for tobacco cessation counseling averaged 3 (SD 0.6) on a 5-point scale from 1 not at all to 5 extremely confident; 76% rated their overall ability to help patients quit using tobacco as fair or poor. Higher confidence ratings were associated with greater perceived overall ability (r 0.58, p 0.001), knowledge (r 0.27, p 0.006), and engagement in the 5-A s (r 0.38, p 0.01). Greater perceived overall ability was significantly associated with engagement in the 5-A s (r 0.42, p 0.001), but not knowledge scores (r 0.18, p 0.073). Training Most residents reported receiving none or inadequate tobacco cessation training in medical school (74%) or residency training (79%), as continuing medical education (97%) or on-the-job training (91%). Adequate training was associated with greater knowledge (r 0.30, p 0.002), confidence (r 0.50, p 0.001), perceived ability (r 0.37, p 0.001), and engagement in the 5-A s (r 0.22, p 0.024). However, among those who rated previous training as adequate, ratings of confidence (mean 3.3) and overall ability (mean 2.4) were still relatively low (5-point scales), and nearly all residents (94%) reported moderate to high interest in learning more about helping their patients quit smoking. Males (r 0.24, p 0.014), current tobacco users (r 0.24, p 0.012), and residents with more negative attitudes toward counseling patients to quit smoking (r 0.37, p 0.001) reported less interest in further training on smoking cessation. Early (N 75) and late (N 30) responders were compared, where late responders were defined as returning their survey after the second mailing. Late responders may serve as proxies for nonrespondents providing a means for assessing survey representativeness (28). Comparisons in Academic Psychiatry, 29:3, July-August 2005

4 PROCHASKA ET AL. dicated no differences between early and late responders on any of the measured variables (all p s 0.05). Discussion This study may be the first to examine the extent to which psychiatry residents are prepared to intervene on nicotine dependence with their patients. The findings reveal low levels of knowledge, confidence, perceived ability, and smoking cessation interventions in clinical practice. Further, engagement in the 5-A s is lower than that reported by clinicians in other medical specialties (29, 30). Lack of training appears to be a major factor. The majority of respondents reported receiving none or inadequate training on tobacco-related interventions in medical school or residency training. While reports of adequate training were associated with greater knowledge, confidence, perceived ability, and engagement in the 5-A s for smoking cessation, levels of confidence and perceived ability were still relatively low, and nearly all (94%) residents reported moderate to high interest in further training for helping their patients quit smoking. The findings demonstrate the need for and interest in tobacco cessation curricula in psychiatry residency training programs. Negative attitudes toward counseling patients to quit smoking were infrequently endorsed overall, suggesting few perceived barriers to implementing cessation interventions in clinical practice. Negative attitudes, however, were more salient among males and residents who reported current tobacco use, and were associated with less interest in further training. For a subset of residents, addressing negative attitudes may be important for increasing receptiveness to training. While smoking rates are lower than found in the general population, significantly higher rates of to- FIGURE 1. Psychiatry Residents Reports of Engagement in the 5-A s for Smoking Cessation Never or rarely Ask about smoking Advise to quit Assess readiness to quit Assist with quitting Arrange to follow-up Sometimes Percent Often or always TABLE 1: Psychiatry Residents Endorsement of Negative Attitudes Related to Counseling Patients to Quit Using Tobacco Mean Rating Attitude (1 strongly disagree, 5 strongly agree) SD % Agree or Strongly Agree A focus on smoking cessation would detract from % management of psychiatric symptoms Asking my patients about their smoking may make them % angry or defensive I don t want to take away an enjoyable and rewarding % activity from my patients I don t ask about their smoking because I don t think they d % be able to quit If my patients want help with quitting smoking, they will ask % for it My patients should wait until their psychiatric issues are % resolved before trying to quit smoking Attempts to quit smoking are likely to make my patients % current drug or alcohol use worse or make them relapse My patients need to smoke to manage their symptoms (e.g., % anxiety, depression) Smoking cessation should preferably be handled by % nonpsychiatric providers Smoking cessation is not a priority for psychiatry % Academic Psychiatry, 29:3, July-August

5 RESIDENTS TREATING NICOTINE DEPENDENCE bacco use have been reported among psychiatry residents and psychiatrists in practice relative to other medical specialties (31, 32). Perhaps related, psychiatrists are less likely to treat tobacco dependence compared to other health care providers (31, 33). Training in tobacco cessation interventions may yield benefits both through encouraging cessation among psychiatrists as well as improving clinical practice. Representativeness of the sample is unknown. Residents were recruited from five programs in northern California, a state with strong antitobacco policies. Nevertheless, residents knowledge, confidence, and behaviors were low. The response rate of 68% is good for a physician survey, and the sample was found to be representative of the recruitment pool. In the literature, response rates for mailed physician surveys average 54% to 61% (34, 35). Factors associated with higher response rates include use of shorter surveys, multiple mailings, stamped return envelopes, and monetary incentives, all elements used in this study (28). Comparison of early and late responders in the current sample revealed no significant group differences, allaying concerns with response bias. Further, nonresponse bias is believed to be less of an issue with physician surveys given the greater homogeneity in knowledge, training, attitudes, and behaviors relative to the general population (28). Smokers with psychiatric disorders have been identified as a priority population (16, 19, 25, 36), and psychiatric treatment encounters provide an ideal but, as yet, untapped opportunity for treating this deadly addiction. Integration of smoking cessation services within psychiatric care is recommended given the specialized needs of mentally ill smokers (19 21). The high rates of tobacco use among the mentally ill and the resulting negative health, social, financial, and treatment consequences cannot be ignored. Without clinical intervention, however, levels of tobacco use are unlikely to change. A focus on training the next generation of psychiatrists may help ensure that changes in clinical practice are achieved and that tobacco interventions are delivered to this high risk group of smokers. This study was supported by the National Institute on Drug Abuse (NIDA) San Francisco Treatment Research Center (grant #P-50 DA-09253); National Institute on Drug Abuse (NIDA) grants #R01 DA-02538, #R01 DA15732, and #T32 DA-07250; the National Institutes of Mental Health (NIMH) grant #R25 MH ; and a Postdoctoral Fellowship from the Tobacco-Related Disease Research Program (#11FT-0013). The authors thank Marc Jacobs, M.D., Alan Louie, M.D., C. Barr Taylor, M.D., Craig Campbell, M.D., and David Goldberg, M.D. for allowing work with the residents in their programs. The authors also thank Lindsay Fletcher for assistance with data management and Karen Hudmon, Dr.PH, MS, R.Ph and Robin Corelli, Pharm.D. for sharing their survey from the Rx for Change curriculum. References 1. Centers for Disease Control and Prevention: Annual smoking-attributable mortality, years of potential life lost, and economic costs United States, Morb Mortal Wkly Rep 2002; 51: Taylor DH Jr, Hasselblad V, Henley SJ, et al: Benefits of smoking cessation for longevity. Am J Public Health 2002; 92: Hughes JR: Taking smoking cessation treatment seriously: the American Psychiatric Association s Practice Guideline for the Treatment of Patients With Nicotine Dependence. Addiction 1998; 93: Lasser K, Boyd JW, Woolhandler S, et al: Smoking and mental illness: a population-based prevalence study. JAMA 2000; 284: Rohde P, Lewinsohn PM, Brown RA, et al: Psychiatric disorders, familial factors and cigarette smoking: I. associations with smoking initiation. Nicotine Tob Res 2003; 5: Centers for Disease Control and Prevention: Prevalence of current cigarette smoking among adults and changes in prevalence of current and some day smoking United States, Morb Mortal Wkly Rep 2003; 52: Acton GS, Prochaska JJ, Kaplan AS, et al: Depression and stages of change for smoking in psychiatric outpatients. Addict Behav 2001; 26: Prochaska JJ, Gill P, Hall SM: Impact of nicotine withdrawal on an adult inpatient psychiatry unit. Psychiatr Serv 2004; 55: Hughes JR: Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment. J Clin Psychiatry 1993; 54: Bruce ML, Leaf PJ, Rozal GP, et al: Psychiatric status and 9- year mortality data in the New Haven Epidemiologic Catchment Area study. Am J Psychiatry 1994; 151: Hurt RD, Offord KP, Croghan IT, et al: Mortality following inpatient addictions treatment: role of tobacco use in a community-based cohort. JAMA 1996; 275: Lichtermann D, Ekelund J, Pukkala E, et al: Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 2001; 58: Ruschena D, Mullen PE, Burgess P, et al: Sudden death in psychiatric patients. Br J Psychiatry 1998; 172: Goff DC, Henderson DC, Amico E: Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 1992; 149: Steinberg ML, Williams JM, Ziedonis DM: Financial implications of cigarette smoking among individuals with schizophrenia. Tob Control 2004; 13: US Public Health Service: A clinical practice guideline for Academic Psychiatry, 29:3, July-August 2005

6 PROCHASKA ET AL. treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA 2000; 283: Fiore MC, Bailey WC, Cohen SJ, et al: Treating Tobacco Use and Dependence: Clinical Practice Guideline. Rockville, Md, US Department of Health and Human Services, Public Health Service, Glynn TJ, Manley MW: How to help your patients stop smoking: A National Cancer Institute manual for physicians. Rockville, Md, US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, American Psychiatric Association: Practice guideline for the treatment of patients with nicotine dependence. Am J Psychiatry 1996; 153(suppl 10): Dalack GW, Glassman AH: A clinical approach to help psychiatric patients with smoking cessation. Psychiatr Q 1992; 63: Hughes JR, Frances RJ: How to help psychiatric patients stop smoking. Psychiatr Serv 1995; 46: Silagy C, Stead LF: Physician advice for smoking cessation. Cochrane Database Syst Rev 2001(2):CD Himelhoch S, Daumit G: To whom do psychiatrists offer smoking-cessation counseling? Am J Psychiatry 2003; 160: Lancaster T, Silagy C, Fowler G: Training health professionals in smoking cessation. Cochrane Database Syst Rev 2000(3):CD Center for Tobacco Cessation: Tobacco dependence among smokers with psychiatric disorders. Edited by Bailey L. Washington, DC, CTC, 2003, pp El-Guebaly N, Cathcart J, Currie S, et al: Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatr Serv 2002; 53: Hudmon KS, Corelli RL, Chung E, et al: Development and implementation of a tobacco cessation training program for students in the health professions. J Cancer Educ 2003; 18: Kellerman SE, Herold J: Physician response to surveys: a review of the literature. Am J Prev Med 2001; 20: Kviz FJ, Clark MA, Prohaska TR, et al: Attitudes and practices for smoking cessation counseling by provider type and patient age. Prev Med 1995; 24: Ward MM, Doebbeling BN, Vaughn TE, et al: Effectiveness of a nationally implemented smoking cessation guideline on provider and patient practices. Prev Med 2003; 36: Frank E, Boswell L, Dickstein L, et al: Characteristics of female psychiatrists. Am J Psychiatry 2001; 158: Hughes PH, Baldwin DC Jr, Sheehan DV, et al: Resident physician substance use, by specialty. Am J Psychiatry 1992; 149: Thorndike AN, Stafford RS, Rigotti NA: US physicians treatment of smoking in outpatients with psychiatric diagnoses. Nicotine Tob Res 2001; 3: Cummings SM, Savitz LA, Konrad TR: Reported response rates to mailed physician questionnaires. Health Serv Res 2001; 35: Asch DA, Jedrziewski MK, Christakis NA: Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997; 50: Interagency Committee on Smoking and Health. Subcommittee on Cessation: Preventing 3 million premature deaths. Helping 5 million smokers quit. A national action plan for tobacco cessation. Edited by Fiore MC. Washington, DC, Interagency Committee on Smoking and Health, 2003 Academic Psychiatry, 29:3, July-August